KERALA AYURVEDA
Back to Income Statement
|
KERALA AYURVEDA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-15 Cr | ₹-1.56 Cr | ₹-0.53 Cr | ₹2.36 Cr | ₹-4.84 Cr |
What is the latest Consolidated Net Profit of KERALA AYURVEDA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-15 Cr |
| Mar2024 | ₹-1.56 Cr |
| Mar2023 | ₹-0.53 Cr |
| Mar2022 | ₹2.36 Cr |
| Mar2021 | ₹-4.84 Cr |
How is Consolidated Net Profit of KERALA AYURVEDA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-15 Cr | Negative | |
| Mar2024 | ₹-1.56 Cr | Negative | |
| Mar2023 | ₹-0.53 Cr | Negative | |
| Mar2022 | ₹2.36 Cr | Positive | |
| Mar2021 | ₹-4.84 Cr | - | |
Compare Consolidated Net Profit of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹287.0 Cr | -4.2% | 36.4% | -29.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,332.0 Cr | 4.1% | -1.3% | -7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,800.0 Cr | 3% | 7.7% | 7.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,578.0 Cr | 2.1% | 0.1% | 26.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,075.0 Cr | 9.3% | 6.6% | 12% | Stock Analytics | |
| CIPLA | ₹105,662.0 Cr | 6.8% | 7.7% | -15.3% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -4.2% |
36.4% |
-29.4% |
| SENSEX | -3% |
5.8% |
-3.4% |
You may also like the below Video Courses